Neat Digest  ·  Archive  ·  Open in app ↗

Biogen, UCB lupus drug dapirolizumab pegol meets phase 3 goal

Score 4.9/10 · Standard · Health · 1 sources · June 1, 2026
Biogen, UCB lupus drug dapirolizumab pegol meets phase 3 goal

Summary: Biogen and UCB announced that their experimental lupus drug,...

Sources on this story

Reported by 1 sources, including:

  • Seeking Alpha